Article

Genomics Improves Risk Stratification of Adults with T-Cell Acute Lymphoblastic Leukemia Patients Enrolled in Measurable Residual Disease-Oriented Trials

2022-02-28

Abstract excerpt

Genetic information has been crucial to understand the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL) at diagnosis and at relapse, but still now a days has a limited value in a clinical context. Few genetic markers are associated with the outcome of T-ALL patients, independently of measurable residual disease (MRD) status after therapy. In addition, the prognostic relevance of genetic features may be...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 74ad450c-1270-5c83-abe0-f5366b1f1e0e
DOI: 10.21203/rs.3.rs-1377009/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genomics Improves Risk Stratification of Adults with T-Cell Acute Lymphoblastic Leukemia Patients Enrolled in Measurable Residual Disease-Oriented TrialsDOI 10.21203/rs.3.rs-1377009/v1Read

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.Semantic proximity Read

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients.Semantic proximity Read

T-cell acute lymphoblastic leukaemia: recent molecular biology findings.Semantic proximity Read

Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort studySemantic proximity Read

The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.Semantic proximity Read

Mutational spectrum of adult T-ALL.Semantic proximity Read

Novel clinical trials for pediatric leukemias: lessons learned from genomic analyses.Semantic proximity Read

Integration of Next-Generation Sequencing to Treat Acute Lymphoblastic Leukemia with Targetable Lesions: The St. Jude Children’s Research Hospital ApproachSemantic proximity Read

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesSemantic proximity Read

DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T‐Cell Acute Lymphoblastic LeukemiaSemantic proximity Read

Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemiaSemantic proximity Read

Mutational patterns in therapy-related acute lymphoblastic leukemia subgroups: one step closer to unveiling the genetic odyssey.Semantic proximity Read